AI-based decision support tools are being developed at a faster rate than ever before but most of those devices lack a code for reimbursement from health insurance, despite FDA’s stamp of approval.
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
“But Brisbane needed to further probe the cancer’s characteristics before recommending a treatment. So, he turned to Unfold AI, a clinical decision support tool that uses artificial intelligence to combine a patient’s biopsy, MRI, and prostate-specific antigen test data to produce a 3D tumor map.”
“On further examination, Brisbane’s patient turned out to be less likely to benefit from the initially projected treatment.”
Brisbane said. “But when I showed the patient this map, it made a lot of sense to him.”
“We were able to spare his nerves really aggressively, because I knew the exact location where I was predicting the cancer coming out of the prostate.”
View Full Article on AI-based decision support Here
